Deficiency of Stabilin-1 in the Context of Hepatic Melanoma Metastasis

CONCLUSIONS: Hepatic melanoma metastases show resistance to Stabilin-1 targeting approaches. This suggests that anti-Stab1 therapies should be considered with respect to the tumor entity or target …